{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:32:08Z","timestamp":1790346728186,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009708","name":"Appalachian State University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.virusres.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:39:42Z","timestamp":1479303582000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers"],"prefix":"10.1016","volume":"228","author":[{"given":"Dylan J.","family":"Fehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2016.10.020_bib0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2012.046","article-title":"Synergistic and selective cancer cell killing mediated by the oncolytic adenoviral mutant AdDeltaDelta and dietary phytochemicals in prostate cancer models","volume":"23","author":"Adam","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2016.10.020_bib0010","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.77.8.4646-4657.2003","article-title":"Ability of M protein of vesicular stomatitis virus to suppress interferon beta gene expression is genetically correlated with the inhibition of host RNA and protein synthesis","volume":"77","author":"Ahmed","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2004.08.039","article-title":"Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses","volume":"330","author":"Ahmed","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2016.10.020_bib0020","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/JVI.02030-08","article-title":"Vesicular stomatitis virus M protein mutant stimulates maturation of TLR7-positive dendritic cells through TLR-dependent and \u2212independent mechanisms","volume":"83","author":"Ahmed","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/cgt.2010.46","article-title":"Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus","volume":"17","author":"Ahmed","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virusres.2016.10.020_bib0030","article-title":"The use of oncolytic vesicular stomatitis virus in conjunction with natural products for the treatment of cervical cancers","volume":"3","author":"Ahmed","year":"2015","journal-title":"Adv. Tech. Biol. Med."},{"key":"10.1016\/j.virusres.2016.10.020_bib0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2217\/imt.13.123","article-title":"Evolution of oncolytic viruses: novel strategies for cancer treatment","volume":"5","author":"Atherton","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.virusres.2016.10.020_bib0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1535-6108(03)00330-1","article-title":"Defective translational control facilitates vesicular stomatitis virus oncolysis","volume":"5","author":"Balachandran","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.virusres.2016.10.020_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1476-4598-12-103","article-title":"Oncolytic viruses as therapeutic cancer vaccines","volume":"12","author":"Bartlett","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.virusres.2016.10.020_bib0050","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2013.187","article-title":"Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis","volume":"21","author":"Ben Yebdri","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2016.10.020_bib0055","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/JVI.67.8.4814-4821.1993","article-title":"The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly","volume":"67","author":"Black","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxsci\/kfj153","article-title":"Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells","volume":"91","author":"Cao","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.virusres.2016.10.020_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01508-08","article-title":"Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus","author":"Carey","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0070","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1210\/en.2006-0502","article-title":"Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak","volume":"147","author":"Castilla","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.virusres.2016.10.020_bib0075","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/carcin\/bgp082","article-title":"Lung tumor promotion by curcumin","volume":"30","author":"Dance-Barnes","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.virusres.2016.10.020_bib0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cgt.2013.55","article-title":"Overcoming cancer cell resistance to VSV oncolysis with JAK1\/2 inhibitors","volume":"20","author":"Escobar-Zarate","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virusres.2016.10.020_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1242\/jcs.115.1.141","article-title":"The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells","volume":"115","author":"Gasparian","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.virusres.2016.10.020_bib0090","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-kappaB pathways in hematological malignancies","volume":"71","author":"Gasparini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.virusres.2016.10.020_bib0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10555-010-9235-2","article-title":"Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals","volume":"29","author":"Gupta","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.virusres.2016.10.020_bib0100","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1099\/vir.0.046672-0","article-title":"Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer","volume":"93","author":"Hastie","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virusres.2016.10.020_bib0110","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.ejca.2013.07.012","article-title":"Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients","volume":"49","author":"Huang","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.virusres.2016.10.020_bib0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/pros.10335","article-title":"Expression of NF-kappaB in prostate cancer lymph node metastases","volume":"58","author":"Ismail","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.virusres.2016.10.020_bib0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood-2008-05-155952","article-title":"Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator","volume":"113","author":"Jiao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virusres.2016.10.020_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2217\/fon.10.18","article-title":"Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?","volume":"6","author":"Kanai","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/138945010791170888","article-title":"Chemosensitization of prostate cancer by modulating Bcl-2 family proteins","volume":"11","author":"Karnak","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.virusres.2016.10.020_bib0135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","article-title":"Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway","volume":"584","author":"Kim","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virusres.2016.10.020_bib0140","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.75.24.12169-12181.2001","article-title":"Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus","volume":"75","author":"Kopecky","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0145","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10408390802248627","article-title":"Fighting cancer with red wine? Molecular mechanisms of resveratrol","volume":"49","author":"Kraft","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.virusres.2016.10.020_bib0150","first-page":"34","article-title":"Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK\/JNK and MEK\/ERK1\/2-mediated targeting NF-\u03baB\/p65 and MUC1-C","volume":"15","author":"Li","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2016.10.020_bib0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jnutbio.2011.01.002","article-title":"Flavokawain B inhibits growth of human squamous carcinoma cells: involvement of apoptosis and cell cycle dysregulation in vitro and in vivo","volume":"23","author":"Lin","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.virusres.2016.10.020_bib0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13238-011-1045-y","article-title":"Retinoic acid inducible gene-I, more than a virus sensor","volume":"2","author":"Liu","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.virusres.2016.10.020_bib0165","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/djj413","article-title":"Effects of intravenously administered recombinant vesicular stomatitis virus (VSV{Delta}M51) on multifocal and invasive gliomas","volume":"98","author":"Lun","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virusres.2016.10.020_bib0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ptr.3171","article-title":"NFkappaB: a promising target for natural products in cancer chemoprevention","volume":"24","author":"Luqman","year":"2010","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.virusres.2016.10.020_bib0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/14756360310001613085","article-title":"Curcumin as a DNA topoisomerase II poison","volume":"18","author":"Martin-Cordero","year":"2003","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.virusres.2016.10.020_bib0180","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/0008-5472.CAN-09-2377","article-title":"Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice","volume":"70","author":"Moussavi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.virusres.2016.10.020_bib0185","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1128\/JVI.77.16.8843-8856.2003","article-title":"Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity","volume":"77","author":"Obuchi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virusres.2014.05.025","article-title":"Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness","volume":"189C","author":"Parrula","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2016.10.020_bib0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jir.2011.0028","article-title":"The role of nuclear factor kappaB in the interferon response","volume":"31","author":"Pfeffer","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virusres.2016.10.020_bib0200","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","article-title":"Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells","volume":"76","author":"Reuter","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pros.21404","article-title":"Expression of NF-kappaB-related proteins and their modulation during TNF-alpha-provoked apoptosis in prostate cancer cells","volume":"72","author":"Rodriguez-Berriguete","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.virusres.2016.10.020_bib0210","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.cellsig.2009.03.009","article-title":"Cellular signaling perturbation by natural products","volume":"21","author":"Sarkar","year":"2009","journal-title":"Cell Signal."},{"key":"10.1016\/j.virusres.2016.10.020_bib0215","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2016.10.020_bib0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/biof.1068","article-title":"Curcumin in various cancers","volume":"39","author":"Shehzad","year":"2013","journal-title":"Biofactors"},{"key":"10.1016\/j.virusres.2016.10.020_bib0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/aging.100296","article-title":"Roles of the Raf\/MEK\/ERK and PI3\u2009K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging","volume":"3","author":"Steelman","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.virusres.2016.10.020_bib0230","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2016.10.020_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell."},{"key":"10.1016\/j.virusres.2016.10.020_bib0240","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.18632\/oncotarget.2550","article-title":"Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition","volume":"5","author":"Tamaki","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.virusres.2016.10.020_bib0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1472-6882-12-246","article-title":"Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells","volume":"12","author":"Waiyaput","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.virusres.2016.10.020_bib0250","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1093\/hmg\/ddq354","article-title":"Resveratrol regulates the PTEN\/AKT pathway through androgen receptor-dependent and \u2212independent mechanisms in prostate cancer cell lines","volume":"19","author":"Wang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.virusres.2016.10.020_bib0255","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2174\/138920112800958850","article-title":"Bugs and drugs: oncolytic virotherapy in combination with chemotherapy","volume":"13","author":"Wennier","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0260","doi-asserted-by":"crossref","first-page":"11733","DOI":"10.1128\/JVI.00971-06","article-title":"Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome","volume":"80","author":"Whitlow","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.10.020_bib0265","doi-asserted-by":"crossref","first-page":"28779","DOI":"10.1074\/jbc.272.45.28779","article-title":"Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1 STAT2, and p48-ISGF3gamma","volume":"272","author":"Wong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2016.10.020_bib0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4161\/cbt.11.2.14405","article-title":"Curcumin: a component of the golden spice, targets multiple angiogenic pathways","volume":"11","author":"Yadav","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.virusres.2016.10.020_bib0275","doi-asserted-by":"crossref","first-page":"25872","DOI":"10.1074\/jbc.M301744200","article-title":"Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase\/Akt pathway in prostate cancer cells","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2016.10.020_bib0280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ijc.25088","article-title":"Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death","volume":"127","author":"Zhang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virusres.2016.10.020_bib0285","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1096\/fj.10-163311","article-title":"Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK\/NF-{kappa}B and MAPK signaling pathways","volume":"24","author":"Zhou","year":"2010","journal-title":"FASEB J."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216304762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216304762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:35:12Z","timestamp":1718901312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170216304762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":57,"alternative-id":["S0168170216304762"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2016.10.020","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}